Main Menu

UW professor discovers new cannabinoid compound that slows cancer cell growth

UW professor discovers new cannabinoid compound that slows cancer cell growth

The medical application of cannabis has been a calling card for marijuana legalization advocates for years, although to date there are just two FDA-approved medications on the market containing cannabinoids.

However, an exciting licensing agreement between the UW and Pascal Biosciences, Inc. means that a cancer treatment derived from cannabinoids could become FDA-approved as soon as 2019.

UW professor discovers new cannabinoid compound that slows cancer cell growth

 






Leave a Reply

Your email address will not be published. Required fields are marked *